128 related articles for article (PubMed ID: 10835684)
1. Therapeutic activity of agonistic monoclonal antibodies against CD40 in a chronic autoimmune inflammatory process.
Mauri C; Mars LT; Londei M
Nat Med; 2000 Jun; 6(6):673-9. PubMed ID: 10835684
[TBL] [Abstract][Full Text] [Related]
2. Treatment of a newly established transgenic model of chronic arthritis with nondepleting anti-CD4 monoclonal antibody.
Mauri C; Chu CQ; Woodrow D; Mori L; Londei M
J Immunol; 1997 Nov; 159(10):5032-41. PubMed ID: 9366431
[TBL] [Abstract][Full Text] [Related]
3. Potent adjuvant effect by anti-CD40 in collagen-induced arthritis. Enhanced disease is accompanied by increased production of collagen type-II reactive IgG2a and IFN-gamma.
Tellander AC; Michaëlsson E; Brunmark C; Andersson M
J Autoimmun; 2000 Jun; 14(4):295-302. PubMed ID: 10882055
[TBL] [Abstract][Full Text] [Related]
4. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
[TBL] [Abstract][Full Text] [Related]
5. Engagement of the CD137 (4-1BB) costimulatory molecule inhibits and reverses the autoimmune process in collagen-induced arthritis and establishes lasting disease resistance.
Foell JL; Diez-Mendiondo BI; Diez OH; Holzer U; Ruck P; Bapat AS; Hoffmann MK; Mittler RS; Dannecker GE
Immunology; 2004 Sep; 113(1):89-98. PubMed ID: 15312139
[TBL] [Abstract][Full Text] [Related]
6. Chronic relapsing homologous collagen-induced arthritis in DBA/1 mice as a model for testing disease-modifying and remission-inducing therapies.
Malfait AM; Williams RO; Malik AS; Maini RN; Feldmann M
Arthritis Rheum; 2001 May; 44(5):1215-24. PubMed ID: 11352257
[TBL] [Abstract][Full Text] [Related]
7. Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis.
Yoshioka T; Nakajima A; Akiba H; Ishiwata T; Asano G; Yoshino S; Yagita H; Okumura K
Eur J Immunol; 2000 Oct; 30(10):2815-23. PubMed ID: 11069062
[TBL] [Abstract][Full Text] [Related]
8. Collagen-induced arthritis in mice: a major role for tumor necrosis factor-alpha.
Williams RO
Methods Mol Biol; 2007; 361():265-84. PubMed ID: 17172717
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to CD40 induce a lethal cytokine cascade after syngeneic bone marrow transplantation.
Hixon JA; Blazar BR; Anver MR; Wiltrout RH; Murphy WJ
Biol Blood Marrow Transplant; 2001; 7(3):136-43. PubMed ID: 11302547
[TBL] [Abstract][Full Text] [Related]
10. Efficient promotion of collagen antibody induced arthritis (CAIA) using four monoclonal antibodies specific for the major epitopes recognized in both collagen induced arthritis and rheumatoid arthritis.
Nandakumar KS; Holmdahl R
J Immunol Methods; 2005 Sep; 304(1-2):126-36. PubMed ID: 16125192
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with an immunodominant peptide of bovine type II collagen induces an anti-TCR response, and modulates the onset and severity of collagen-induced arthritis.
Honda A; Ametani A; Matsumoto T; Iwaya A; Kano H; Hachimura S; Ohkawa K; Kaminogawa S; Suzuki K; Sercarz EE; Kumar V
Int Immunol; 2004 May; 16(5):737-45. PubMed ID: 15096482
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic role of B cells in anti-CD40-induced necroinflammatory liver disease.
Kimura K; Moriwaki H; Nagaki M; Saio M; Nakamoto Y; Naito M; Kuwata K; Chisari FV
Am J Pathol; 2006 Mar; 168(3):786-95. PubMed ID: 16507894
[TBL] [Abstract][Full Text] [Related]
13. 4-1BB-mediated immunotherapy of rheumatoid arthritis.
Seo SK; Choi JH; Kim YH; Kang WJ; Park HY; Suh JH; Choi BK; Vinay DS; Kwon BS
Nat Med; 2004 Oct; 10(10):1088-94. PubMed ID: 15448685
[TBL] [Abstract][Full Text] [Related]
14. Protection of marmoset monkeys against EAE by treatment with a murine antibody blocking CD40 (mu5D12).
Laman JD; 't Hart BA; Brok H; Meurs Mv; Schellekens MM; Kasran A; Boon L; Bauer J; Boer Md; Ceuppens J
Eur J Immunol; 2002 Aug; 32(8):2218-28. PubMed ID: 12209634
[TBL] [Abstract][Full Text] [Related]
15. CD40 antibody as an adjuvant induces enhanced T cell responses.
Carlring J; Barr TA; McCormick AL; Heath AW
Vaccine; 2004 Sep; 22(25-26):3323-8. PubMed ID: 15308355
[TBL] [Abstract][Full Text] [Related]
16. Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis.
Murakami Y; Akahoshi T; Aoki N; Toyomoto M; Miyasaka N; Kohsaka H
Arthritis Rheum; 2009 Jun; 60(6):1615-23. PubMed ID: 19479878
[TBL] [Abstract][Full Text] [Related]
17. Enhancing effects of anti-CD40 treatment on the immune response of SCID-bovine mice to Trypanosoma congolense infection.
Haas KM; Taylor KA; MacHugh ND; Kreeger JM; Estes DM
J Leukoc Biol; 2001 Dec; 70(6):931-40. PubMed ID: 11739556
[TBL] [Abstract][Full Text] [Related]
18. Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells.
Fan K; Dai J; Wang H; Wei H; Cao Z; Hou S; Qian W; Wang H; Li B; Zhao J; Xu H; Yang C; Guo Y
Arthritis Rheum; 2008 Jul; 58(7):2041-52. PubMed ID: 18576331
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody against T-cell receptor alphabeta induces self-tolerance in chronic experimental autoimmune encephalomyelitis.
Lavasani S; Dzhambazov B; Andersson M
Scand J Immunol; 2007 Jan; 65(1):39-47. PubMed ID: 17212765
[TBL] [Abstract][Full Text] [Related]
20. The use of agonistic anti-CD40 therapy in treatments for cancer.
Khong A; Nelson DJ; Nowak AK; Lake RA; Robinson BW
Int Rev Immunol; 2012 Aug; 31(4):246-66. PubMed ID: 22804570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
